Mefenamic Acid Teva Uk

Mefenamic Acid, the active ingredient in Mefenamic Acid Teva Uk, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats mild to moderate pain, dysmenorrhea, and inflammatory musculoskeletal conditions in adults. GNH USA supplies Mefenamic Acid Teva Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mefenamic Acid is an NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, and postoperative discomfort. - Dysmenorrhea: alleviates menstrual cramps associated with primary dysmenorrhea. - Inflammatory musculoskeletal conditions: reduces pain and swelling in arthritis, sprains, and tendonitis.

Mefenamic Acid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Diarrhea or constipation. - Headache. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or worsening of chronic kidney disease. - Hepatic dysfunction, including elevated liver enzymes. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylaxis or other severe hypersensitivity reactions.

Before prescribing Mefenamic Acid, clinicians should evaluate patient‑specific risk factors and follow safe handling practices.

- Assess renal function: monitor creatinine in patients with kidney disease. - Evaluate gastrointestinal risk: avoid in patients with active ulcer disease or a history of GI bleeding. - Consider cardiovascular risk: use cautiously in patients with hypertension or heart disease. - Avoid in known hypersensitivity to mefenamic acid or other NSAIDs. - Pregnancy and lactation: use only if benefits outweigh risks; safety not established. - Store at ambient temperature: keep below 25°C, protect from moisture and light in the original container.

Mefenamic Acid can alter the activity of several co‑administered medicines; interaction severity varies.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Lithium: NSAIDs may raise lithium plasma concentrations. - Methotrexate: reduced clearance leading to toxicity. - Diuretics (e.g., furosemide): may impair renal perfusion.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible reduction of antihypertensive effect. - Beta‑blockers: potential impact on renal function. - Cyclosporine: increased risk of nephrotoxicity.